Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Venu Menon, MD, is a staff cardiologist in the Section of Cardiovascular Imaging and Director of the Coronary Care Unit in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified in internal medicine, cardiovascular diseases, nuclear cardiology and echocardiography. His specialty interests include critical care cardiology, cardiovascular imaging, echocardiography and valve disease and the conduct of clinical trials.
Dr. Menon received his medical degree from the J.I.P.M.E.R. Medical School, Madras University in Pondicherry, India. He took an internship in internal medicine at St. Luke's-Roosevelt Hospital, College of Physician and Surgeons, in New York, where he received the Chief Resident's Award as well as the Michael Rauchman award for best graduating resident. He went on to complete his fellowship training in cardiovascular disease, and continued his research training as a Clinical Research Fellow on the NIH-supported SHOCK Trial.
Dr. Menon has held several academic appointments. He was an Assistant Professor of Clinical Medicine at Columbia College of Physicians and Surgeons, and Assistant Professor of Medicine and Assistant Professor of Emergency Medicine at the University of North Carolina School of Medicine. He was the recipient of the Distinguished Faculty Award as Outstanding Teacher of the Year (2001-2002) while in New York. During his tenure at UNC School of Medicine, he was named Educator of the Year and was inducted into the Alpha Omega Alpha Medical Honor Society.
Prior to his 2005 appointment to Cleveland Clinic as Staff Cardiologist, Dr. Menon was Director of the Coronary Care Unit and Director of the Chest Pain Unit at the University of North Carolina Hospitals. Prior to this appointment, he was Assistant Director of Cardiac Research at St. Luke's-Roosevelt Hospital Center. Apart from his clinical duties at the Cleveland Clinic Dr Menon is also Associate Director of the Cardiovascular Fellowship Program and Director of the the Clinical Events Committe of C5.
Dr. Menon is a reviewer for the American Heart Journal, the American Journal of Cardiology, the European Heart Journal, Journal of the American College of Cardiology, Heart and the American Journal of Medicine.
His research interests have focused on early revascularization for cardiogenic shock as well as the late open artery hypothesis. He has published his research in leading peer-reviewed medical journals. He has edited, authored or co-authored textbooks and chapters in medical textbooks on chronic coronary artery disease, noninvasive cardiac testing and accute coronary syndromes. He has been invited to lecture on his specialty interests throughout the United States and Canada.
Dr. Menon is a fellow of the American College of Cardiology and the American Heart Association and a member of the American Society of Echocardiography.
Heart Valve Disease, Angina, Cardiovascular Imaging, Echocardiogram, Heart Attack, Cardiac Intensive Care
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/22/2013, Dr. Menon has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.